Cargando…
Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer
Ubiquitin-specific protease 22 (USP22), a novel ubiquitin hydrolase, has been implicated in oncogenesis and cancer progression in various types of human cancer. However, the clinical significance of USP22 expression in non-small cell lung cancer (NSCLC) has not been determined. In the present study,...
Autores principales: | Ning, J., Zhang, J., Liu, W., Lang, Y., Xue, Y., Xu, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567765/ https://www.ncbi.nlm.nih.gov/pubmed/23361242 http://dx.doi.org/10.4081/ejh.2012.e46 |
Ejemplares similares
-
Ubiquitin‐specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis
por: Fang, Chia‐Lang, et al.
Publicado: (2018) -
Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis
por: Ao, Ning, et al.
Publicado: (2017) -
Overexpression of Ubiquitin-Specific Protease15 (USP15) Promotes Tumor Growth and Inhibits Apoptosis and Correlated With Poor Disease-Free Survival in Hepatocellular Carcinoma
por: Yao, Xue-Qing, et al.
Publicado: (2020) -
Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1
por: Lin, Zhenghong, et al.
Publicado: (2015) -
Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma
por: Zhao, Hua-Dong, et al.
Publicado: (2016)